The biosynthesis of the basement-membrane glycoprotein laminin in the mouse teratocarcinoma cell line PFHR9 was studied by immunoelectron microscopy and pulse-chase experiments using monoclonal and polyclonal antibodies. By immunoelectron microscopy, most of the protein was found to be aggregated on the outer cell surface. Cytoplasmic stainings were rare and were located next to the intracellular side of the plasma membrane. Sequential immunoprecipitations of cell extracts with a monoclonal antibody (4C12) sensitive to the laminin native conformation and with a polyclonal antibody enables laminin, the B1 subunit and a 410 kDa molecule to be distinguished. Most of the laminin is of the A(B1B2) type, and the 410 kDa molecule appears to be a B1B2 heterodimer. The assembly of laminin from subunits is completed in less than 1 h, and B chains are incorporated via the formation of the B heterodimers. The B2 and A chains are not found as free forms, so their levels appear to be the rate-limiting factors for the assembly of the dimers and laminin respectively. The formation of an uncross-linked A(B1B2) complex as a short-lived intermediate in the biosynthetic process is possible. Together with immunoelectron microscopy, the present study suggests that the protein is rapidly exported after assembly to accumulate on the outer side of the cell membrane. The biosynthesis of laminin in the PFHR9 cell line appears to be similar to that in other matrix-producing cell lines.
Skip Nav Destination
Follow us on Twitter @Biochem_Journal
Article navigation
March 1988
-
Cover Image
Cover Image
- PDF Icon PDF LinkFront Matter
- PDF Icon PDF LinkTable of Contents
- PDF Icon PDF LinkAdvertising
Research Article|
March 15 1988
Laminin biosynthesis in the extracellular matrix-producing cell line PFHR9 studied with monoclonal and polyclonal antibodies
J C S Lissitzky;
J C S Lissitzky
*Laboratoire de Cancérologie Expérimentale, UA CNRS 1175, Faculté de Médecine Nord, Boulevard Pierre Dramard, 13326 Marseille Cedex 15, France
Search for other works by this author on:
C Charpin;
C Charpin
†Laboratoire de Neuroanatomopathologie, Faculté de Médecine, Boulevard Jean Moulin, 13005 Marseille Cedex 5, France
Search for other works by this author on:
C Bignon;
C Bignon
*Laboratoire de Cancérologie Expérimentale, UA CNRS 1175, Faculté de Médecine Nord, Boulevard Pierre Dramard, 13326 Marseille Cedex 15, France
Search for other works by this author on:
M Bouzon;
M Bouzon
*Laboratoire de Cancérologie Expérimentale, UA CNRS 1175, Faculté de Médecine Nord, Boulevard Pierre Dramard, 13326 Marseille Cedex 15, France
Search for other works by this author on:
F Kopp;
F Kopp
*Laboratoire de Cancérologie Expérimentale, UA CNRS 1175, Faculté de Médecine Nord, Boulevard Pierre Dramard, 13326 Marseille Cedex 15, France
Search for other works by this author on:
P Delori;
P Delori
*Laboratoire de Cancérologie Expérimentale, UA CNRS 1175, Faculté de Médecine Nord, Boulevard Pierre Dramard, 13326 Marseille Cedex 15, France
Search for other works by this author on:
P M Martin
P M Martin
*Laboratoire de Cancérologie Expérimentale, UA CNRS 1175, Faculté de Médecine Nord, Boulevard Pierre Dramard, 13326 Marseille Cedex 15, France
Search for other works by this author on:
Publisher: Portland Press Ltd
Online ISSN: 1470-8728
Print ISSN: 0264-6021
© 1988 London: The Biochemical Society
1988
Biochem J (1988) 250 (3): 843–852.
Citation
J C S Lissitzky, C Charpin, C Bignon, M Bouzon, F Kopp, P Delori, P M Martin; Laminin biosynthesis in the extracellular matrix-producing cell line PFHR9 studied with monoclonal and polyclonal antibodies. Biochem J 15 March 1988; 250 (3): 843–852. doi: https://doi.org/10.1042/bj2500843
Download citation file:
Sign in
Don't already have an account? Register
Sign in to your personal account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Biochemical Society Member Sign in
Sign InSign in via your Institution
Sign in via your InstitutionGet Access To This Article
Follow us on Twitter @Biochem_Journal
Open Access for all
We offer compliant routes for all authors from 2025. With library support, there will be no author nor reader charges in 5 journals. Check here |
View past webinars > |